Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240104060610N1Phase 2Completed
Phase 2 trial of DehydraTECH-estrogen in vaginal atrophy and genitourinary syndrome of menopause (GSM) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Improvement in vaginal atrophy symptoms. Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240104060610N1.